HCW Biologics develops pembrolizumab-based cancer treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. MRK
6. HD
7. SPY
8. DVLT
9. MRCY
10. LOW

Go back to HCW Biologics develops pembrolizumab-based cancer treatment
(NASDAQ: HCWB) Delayed: 2.30 +0.17 (7.98%)
Previous Close $2.13    52 Week High $ 
Open $2.14    52 Week Low $ 
Day High $2.40    P/E N/A 
Day Low $2.13    EPS $ 
Volume 103,358